Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.

Aleksander Ślusarczyk,Michael Baboudjian,Piotr Zapała,Takafumi Yanagisawa,Marcin Miszczyk,Marcin Chlosta,Paul Krumpoeck,Marco Moschini,Giorgio Gandaglia,Guillaume Ploussard,Juan G Rivas,Marcin Życzkowski,Pierre I Karakiewicz,Piotr Radziszewski,Michael S Leapman,Shahrokh F Shariat,Paweł Rajwa

The Prostate（2023）

引用 0|浏览7

暂无评分

摘要

Patients treated with local therapy for nmPCa with very high PSA at diagnosis have relatively good long-term oncological outcomes. Therefore, among well-selected patients with nmPCa, high PSA levels alone should not preclude the use of radical local therapy. Potential selection bias limits inferences about the relative effectiveness of specific local therapies in this setting.

查看译文

关键词

high PSA, nonmetastatic prostate cancer, prostate-specific antigen, radical prostatectomy, radiotherapy, survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要